Counterfeit Drugs a $30 billion business

WHO analyzed “100 studies from 2007 to 2016, covering more than 48,000 samples, [which] showed 10.5 percent of drugs in low and middleincome countries to be fake or substandard. With pharmaceutical sales in such countries running at nearly $300 billion a year, this implies that trade in fake medicines is a $30 billion business